Diamond Hill Capital Management LLC Investment Advisor Takes Position in Revvity Inc. $RVTY

Posted by Brenda Bartman on Aug 17th, 2026

Diamond Hill Capital Management LLC Investment Advisor purchased a new position in Revvity Inc. (NYSE:RVTY – Free Report) during the second quarter, HoldingsChannel reports. The firm purchased 385,296 shares of the company’s stock, valued at approximately $42,868,000.

Several other large investors also recently modified their holdings of the company. New Mexico Educational Retirement Board increased its position in Revvity by 1.9% during the fourth quarter. New Mexico Educational Retirement Board now owns 5,416 shares of the company’s stock valued at $524,000 after acquiring an additional 100 shares during the last quarter. Allworth Financial LP boosted its position in Revvity by 8.9% in the fourth quarter. Allworth Financial LP now owns 1,275 shares of the company’s stock worth $123,000 after purchasing an additional 104 shares during the last quarter. EverSource Wealth Advisors LLC boosted its position in Revvity by 17.0% in the first quarter. EverSource Wealth Advisors LLC now owns 749 shares of the company’s stock worth $66,000 after purchasing an additional 109 shares during the last quarter. HighTower Advisors LLC grew its stake in shares of Revvity by 2.6% during the 4th quarter. HighTower Advisors LLC now owns 5,141 shares of the company’s stock valued at $497,000 after purchasing an additional 129 shares during the period. Finally, Cary Street Partners Financial LLC grew its stake in shares of Revvity by 1.6% during the 4th quarter. Cary Street Partners Financial LLC now owns 8,941 shares of the company’s stock valued at $865,000 after purchasing an additional 141 shares during the period. Institutional investors own 86.65% of the company’s stock.

Revvity Stock Performance

Shares of RVTY opened at $116.71 on Monday. The company has a quick ratio of 1.50, a current ratio of 1.80 and a debt-to-equity ratio of 0.36. The business has a 50-day simple moving average of $109.62 and a two-hundred day simple moving average of $99.98. The stock has a market cap of $13.02 billion, a price-to-earnings ratio of 55.58, a PEG ratio of 2.13 and a beta of 1.07. Revvity Inc. has a 52 week low of $81.22 and a 52 week high of $118.34.

Revvity (NYSE:RVTY – Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, topping the consensus estimate of $1.21 by $0.20. Revvity had a return on equity of 8.34% and a net margin of 8.16%.The firm had revenue of $729.69 million for the quarter, compared to the consensus estimate of $702.96 million. During the same quarter last year, the company earned $1.18 earnings per share. The business’s revenue for the quarter was down 1.3% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. On average, analysts expect that Revvity Inc. will post 5.36 EPS for the current year.

Revvity Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be paid a dividend of $0.07 per share. The ex-dividend date is Friday, October 23rd. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. Revvity’s dividend payout ratio (DPR) is presently 13.33%.

Analysts Set New Price Targets

RVTY has been the topic of several recent research reports. Weiss Ratings upgraded shares of Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 30th. JPMorgan Chase & Co. cut their target price on shares of Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a research report on Wednesday, May 6th. Wall Street Zen cut shares of Revvity from a “buy” rating to a “hold” rating in a report on Sunday. Zacks Research upgraded shares of Revvity from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 4th. Finally, Wolfe Research started coverage on shares of Revvity in a research report on Tuesday, June 2nd. They issued a “peer perform” rating on the stock. Three equities research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $108.36.

Read Our Latest Research Report on Revvity

Revvity Profile

(Free Report)

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.